angiotensin ii has been researched along with Thrombosis in 59 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 24 (40.68) | 18.7374 |
1990's | 8 (13.56) | 18.2507 |
2000's | 11 (18.64) | 29.6817 |
2010's | 13 (22.03) | 24.3611 |
2020's | 3 (5.08) | 2.80 |
Authors | Studies |
---|---|
Berthelot, JM; Drouet, L; Lioté, F | 1 |
Belloni, L; Fama, A; Giuri, PG; Negro, A; Penna, D; Zerbini, A | 1 |
Balestrieri, A; Barcellona, D; Caocci, G; Castagnola, M; Cau, R; Coghe, F; Coni, P; D'Andrea, F; Faa, G; Fanni, D; Gerosa, C; La Nasa, G; Ledda, F; Marongiu, F; Orru, G; Piras, M; Ronchi, A; Saba, L; Suri, JS | 1 |
Antoku, Y; Egashira, K; Honda, K; Ichi, I; Koga, JI; Matoba, T; Nakano, K; Tsutsui, H | 1 |
Gavins, FNE; Granger, DN; Orr, AW; Russell, J; Senchenkova, EY; Vital, SA; Yildirim, A | 1 |
Gavins, FNE; Granger, DN; Russell, J; Senchenkova, EY; Yildirim, A | 1 |
Chabielska, E; Kamińska, M; Musiał, W | 1 |
Becker, C; Daiber, A; Daub, S; Grabbe, S; Hausding, M; Jansen, T; Jurk, K; Kerahrodi, JG; Kossmann, S; Kröller-Schön, S; Mikhed, Y; Münzel, T; Oelze, M; Reske-Kunz, AB; Schulz, E; Schwenk, M; Stein, J; Wenzel, P | 1 |
Esmon, CT; Granger, DN; Russell, J; Senchenkova, EY | 1 |
Ishii, M; Kubota, R; Matsushita, T; Morita, Y; Murohara, T; Numaguchi, Y; Okumura, K; Yamamoto, K | 1 |
Chabielska, E; Malinowska-Zaprzałka, M; Stankiewicz, A; Wojewódzka-Zelezniakowicz, M | 1 |
Buczko, W; Kramkowski, K; Leszczynska, A; Mogielnicki, A | 1 |
Almeida-Paula, LD; Granger, DN; Harding, JW; Russell, J; Senchenkova, EY | 1 |
Celi, A; Cianchetti, S; Dell'Omo, G; Pedrinelli, R | 1 |
Ali, BH; Fahim, MA; Nemmar, A; Subramaniyan, D; Zia, S | 1 |
Granger, DN; Kurmaeva, E; Ostanin, D; Russell, J; Senchenkova, EY | 1 |
Collins, MJ; Holzapfel, GA; Humphrey, JD; Niklason, LE; Pierce, DM; Schriefl, AJ | 1 |
Adams, GN; Bilodeau, ML; Chen, A; Fang, C; Grobe, N; LaRusch, G; Mahdi, F; Morris, M; Nieman, MT; Schmaier, AA; Schmaier, AH; Stavrou, E; Warnock, M; Zhou, Y | 1 |
Siegel-Axel, DI | 1 |
Goette, A; Lendeckel, U | 1 |
Bataller, R; Brenner, DA; Gäbele, E; Morris, T; Parsons, CJ; Rippe, RA; Schoonhoven, R; Yang, L | 1 |
Chiarelli, F; Di Marzio, D; Giannini, C; Mohn, A; Mokini, ZH | 1 |
Ageno, W; Dentali, F; Romualdi, E | 1 |
Blanco-Colio, LM; Egido, J; Martín-Ventura, JL; Tarín, N; Tuñón, J | 1 |
Dobbie, JW; Isles, CG; Lever, AF; Sawyer, A; Vance, JP | 1 |
Biryńczyk, J; Kostka-Wach, M; Lehmann, Z; Stasiński, T; Warenik-Szymankiewicz, A | 1 |
Lazos, SA; Tong, K; Vaughan, DE | 1 |
Fogo, A; Freeman, M; Lo, W; Oikawa, T; Vaughan, DE | 1 |
Abe, S; Kinukawa, N; Nakamura, M | 1 |
Gordon, G; Kirsch, RE; Levitt, NS; Lombard, CJ; Raine, R; Robson, SC; Trey, G; Voigt, MD | 1 |
Achard, JM; Dieval, J; Fournier, A; Hottelart, C; Moriniere, P; Zoghbi, F | 1 |
Beevers, DG; Headon, M; Jones, AF; Lip, GY; Lip, PL; Price, N | 1 |
Brown, NJ; Vaughan, DE | 1 |
Buczko, W; Chabielska, E; Kucharewicz, I; Matys, T | 1 |
Edgington, TS | 1 |
Bavry, AA; Li, D; Mehta, JL; Phillips, MI; Zander, DS | 1 |
Ahonen, J; Fyhrquist, F; Lindfors, O; von Bonsdorff, M; von Knorring, J | 1 |
Brown, JJ; Cuesta, V; Davies, DL; Lever, AF; Morton, JJ; Padfield, PL; Robertson, JI; Trust, P | 1 |
Hollander, W | 1 |
McGiff, JC | 1 |
Novak, D; Weber, J | 1 |
Berg, S; Spark, RF | 1 |
Becker, RC | 1 |
Abildgaard, U; Agerskov, K; Amtorp, O; Christensen, NJ; Henriksen, O; Sjøntoft, E | 1 |
Shimamoto, T | 1 |
Scheitlin, WA | 1 |
Bonnin, JM; Edwards, RG; Scroop, GC; Skinner, SL; Whelan, RF | 1 |
Bergan, JJ; Conn, J; Haid, SP | 1 |
Dahn, I; Hallböök, T; Larsen, OA; Lassen, NA; Nilsén, R; Westling, H | 1 |
Bologna, E | 1 |
Bollinger, A | 1 |
Fournier, A | 1 |
Ekelund, L; Göthlin, J; Olin, T | 1 |
Wood, JE | 1 |
Kincaid-Smith, P | 1 |
Khairallah, PA; Robertson, AL | 1 |
Bunce, I; Dowling, SV; Nicoll, P; Whitaker, AN | 1 |
Bunce, I; Knowles, BR; Richardson, ER; Whitaker, AN | 1 |
Whitaker, AN | 1 |
18 review(s) available for angiotensin ii and Thrombosis
Article | Year |
---|---|
Kawasaki-like diseases and thrombotic coagulopathy in COVID-19: delayed over-activation of the STING pathway?
Topics: Angiotensin II; Animals; Aspirin; Blood Coagulation Disorders; Coronavirus Infections; COVID-19; Dipyridamole; Humans; Immunoglobulins, Intravenous; Interferons; Membrane Proteins; Mice; Mucocutaneous Lymph Node Syndrome; Pandemics; Platelet Aggregation Inhibitors; Pneumonia, Viral; Signal Transduction; Thrombosis | 2020 |
Molecular pathways triggered by COVID-19 in different organs: ACE2 receptor-expressing cells under attack? A review.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Atrial Fibrillation; Blood Coagulation; Capillary Permeability; Cardiomyopathies; COVID-19; Cytokine Release Syndrome; Cytokines; Endothelium, Vascular; Fibroblasts; Fibrosis; Humans; Liver Cirrhosis; Myocarditis; Receptors, Coronavirus; Renin-Angiotensin System; SARS-CoV-2; Systemic Inflammatory Response Syndrome; Thrombosis; Virus Internalization | 2020 |
[Angiotensin II: the risk factor for arterial thrombosis].
Topics: Angiotensin II; Animals; Biomarkers; Blood Coagulation; Blood Platelets; Fibrinolysis; Humans; Oxidation-Reduction; Peripheral Arterial Disease; Platelet Aggregation; Renin-Angiotensin System; Risk Factors; Thrombosis | 2013 |
[The influence of tissue and plasma angiotensin converting enzyme inhibitors on haemostasis with respect to experimental and clinical investigations].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Endothelium, Vascular; Epoprostenol; Hemostasis; Humans; Thrombosis; Tissue Plasminogen Activator | 2005 |
Angiotensin II, tissue factor and the thrombotic paradox of hypertension.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Endothelium, Vascular; Humans; Hypertension; Renin; Renin-Angiotensin System; Risk Factors; Thromboplastin; Thrombosis | 2010 |
Cerivastatin: a cellular and molecular drug for the future?
Topics: Angiotensin II; Animals; Anticholesteremic Agents; Arteriosclerosis; Endothelium, Vascular; Epoprostenol; Extracellular Matrix; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperlipidemias; Hypolipidemic Agents; Monocytes; Muscle, Smooth, Vascular; Neovascularization, Physiologic; Pyridines; Receptors, Angiotensin; Thrombosis | 2003 |
Nonchannel drug targets in atrial fibrillation.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Antioxidants; Atrial Fibrillation; Humans; Metalloproteases; Myocardium; Oxidative Stress; Thrombosis | 2004 |
Macroangiopathy in adults and children with diabetes: from molecular mechanisms to vascular damage (part 1).
Topics: Adult; Angiotensin I; Angiotensin II; Atherosclerosis; Child; Cholesterol, LDL; Diabetic Angiopathies; Fatty Liver; Humans; Inflammation; Macrophages; Thrombosis | 2006 |
Common pathways of hypercholesterolemia and hypertension leading to atherothrombosis: the need for a global approach in the management of cardiovascular risk factors.
Topics: Angiotensin II; Cardiovascular Diseases; Humans; Hypercholesterolemia; Hypertension; Risk Factors; Thrombosis | 2007 |
[Effect of oral contraceptives on the circulatory system].
Topics: Aldosterone; Angiotensin II; Cardiovascular Diseases; Cerebrovascular Disorders; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Coronary Disease; Female; Humans; Hypertension; Renin; Stimulation, Chemical; Thrombosis | 1980 |
Prothrombotic effects of angiotensin.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensins; Blood Coagulation; Blood Platelets; Bradykinin; Fibrinolysis; Fibrinolytic Agents; Free Radical Scavengers; Humans; Nitric Oxide; Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Renin-Angiotensin System; Serine Proteinase Inhibitors; Superoxides; Thrombosis; Tissue Plasminogen Activator | 2000 |
The role of endothelium in antithrombotic effect of the renin-angiotensin system blockade.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Clinical Trials as Topic; Endothelium, Vascular; Epoprostenol; Fibrinolytic Agents; Humans; Nitric Oxide; Renin-Angiotensin System; Thrombosis | 1999 |
Role of hypertension in atherosclerosis and cardiovascular disease.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Arteriosclerosis; Blood Platelets; Capillary Permeability; Cardiomegaly; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Disease; Death, Sudden; Endothelium; Histamine; Humans; Hypertension; Lipids; Lysosomes; Muscle, Smooth; Renin; Serotonin; Thrombosis | 1976 |
Prostaglandins in circulatory disorders.
Topics: Angiotensin II; Antihypertensive Agents; Arachidonic Acids; Arteriosclerosis; Aspirin; Blood Platelets; Diet; Dipyridamole; Eicosanoic Acids; Humans; Hypertension; Platelet Aggregation; Prostaglandins; Thrombosis; Thromboxanes; Vascular Diseases | 1979 |
Seminars in thrombosis, thrombolysis and vascular biology. 1. The vascular endothelium.
Topics: Angioplasty, Balloon, Coronary; Angiotensin II; Coronary Artery Bypass; Endothelins; Endothelium, Vascular; Epoprostenol; Humans; Myocardial Reperfusion Injury; Nitric Oxide; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator; Vasomotor System | 1991 |
[Renal-vascular hypertension].
Topics: Adolescent; Adult; Aged; Aneurysm; Angiotensin II; Animals; Aortic Diseases; Arteriovenous Fistula; Child; Embolism; Female; Humans; Hypertension, Renal; Kidney Diseases; Male; Middle Aged; Radioisotope Renography; Renal Artery; Renal Artery Obstruction; Thrombosis; Vascular Diseases | 1967 |
The cardiovascular effects of oral contraceptives.
Topics: Aldosterone; Angiotensin II; Blood Coagulation; Blood Flow Velocity; Blood Vessels; Cardiovascular System; Cerebrovascular Disorders; Contraceptives, Oral; Estrogens; Female; Humans; Hypertension; Migraine Disorders; Muscle, Smooth; Myocardial Infarction; Platelet Adhesiveness; Pregnancy; Pulmonary Embolism; Renin; Thromboembolism; Thrombosis; Varicose Veins; Veins | 1972 |
Coagulation and renal disease.
Topics: Acute Kidney Injury; Angiotensin II; Animals; Anticoagulants; Blood Coagulation; Blood Coagulation Disorders; Catecholamines; Disseminated Intravascular Coagulation; Female; Fibrin; Heparin; Humans; Hypertension, Renal; Kidney Diseases; Kidney Glomerulus; Pre-Eclampsia; Pregnancy; Renin; Thrombosis; Uremia | 1972 |
1 trial(s) available for angiotensin ii and Thrombosis
Article | Year |
---|---|
Heparin-induced hyperkalemia in chronic hemodialysis patients: comparison of low molecular weight and unfractionated heparin.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Anticoagulants; Bicarbonates; Creatinine; Cross-Over Studies; Diet; Female; Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Humans; Hyperkalemia; Hypoaldosteronism; Linear Models; Male; Middle Aged; Phosphates; Potassium; Prospective Studies; Renal Dialysis; Renin; Thrombosis; Urea | 1998 |
40 other study(ies) available for angiotensin ii and Thrombosis
Article | Year |
---|---|
SFLT-1 levels in COVID-19 patients: Association with outcome and thrombosis.
Topics: Angiotensin II; COVID-19; Humans; Placenta Growth Factor; SARS-CoV-2; Thrombosis | 2021 |
Lipid-Lowering Therapy With Ezetimibe Decreases Spontaneous Atherothrombotic Occlusions in a Rabbit Model of Plaque Erosion: A Role of Serum Oxysterols.
Topics: Angiotensin II; Animals; Anticholesteremic Agents; Arterial Occlusive Diseases; Atherosclerosis; Biomarkers; Cells, Cultured; Cholesterol, Dietary; Diet, High-Fat; Disease Models, Animal; Down-Regulation; Ezetimibe; Femoral Artery; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Oxysterols; Plaque, Atherosclerotic; Rabbits; Rats; Rosuvastatin Calcium; Signal Transduction; Thrombosis; Vascular System Injuries | 2018 |
A critical role for both CD40 and VLA5 in angiotensin II-mediated thrombosis and inflammation.
Topics: Angiotensin II; Animals; CD40 Antigens; CD40 Ligand; Humans; Inflammation; Integrin alpha5beta1; Male; Mice; Mice, Knockout; Signal Transduction; Thrombosis | 2018 |
Novel Role of T Cells and IL-6 (Interleukin-6) in Angiotensin II-Induced Microvascular Dysfunction.
Topics: Adaptive Immunity; Angiotensin II; Animals; Blood Pressure; Disease Models, Animal; Flow Cytometry; Hypertension; Interleukin-6; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microcirculation; Signal Transduction; T-Lymphocytes; Thrombosis | 2019 |
CD40L contributes to angiotensin II-induced pro-thrombotic state, vascular inflammation, oxidative stress and endothelial dysfunction.
Topics: Angiotensin II; Animals; Aorta; Blotting, Western; CD40 Ligand; Endothelial Cells; Flow Cytometry; Immunohistochemistry; Inflammation; Leukocytes; Mice; Mice, Inbred C57BL; Mice, Knockout; Oxidative Stress; Platelet Activation; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Thrombosis; Vascular Diseases | 2013 |
Roles of Coagulation and fibrinolysis in angiotensin II-enhanced microvascular thrombosis.
Topics: Angiotensin II; Animals; Antithrombin III; Antithrombins; Fibrinolysis; Hemostatics; Male; Mice; Mice, Knockout; Microvessels; Protein C; Serpin E2; Thrombin; Thromboplastin; Thrombosis; Vasoconstrictor Agents | 2014 |
Ablation of angiotensin IV receptor attenuates hypofibrinolysis via PAI-1 downregulation and reduces occlusive arterial thrombosis.
Topics: Angiotensin II; Animals; Cells, Cultured; Disease Models, Animal; Down-Regulation; Endothelial Cells; Fibrinolysis; Hemodynamics; Hemostasis; Kidney Glomerulus; Lipopolysaccharides; Mice; Mice, Knockout; Receptors, Angiotensin; RNA, Messenger; Serpin E2; Serpins; Signal Transduction; Thrombosis; Tissue Plasminogen Activator | 2009 |
Angiotensin-(1-9), the product of angiotensin I conversion in platelets, enhances arterial thrombosis in rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Arteries; Blood Platelets; Humans; Losartan; Male; Partial Thromboplastin Time; Peptide Fragments; Platelet Aggregation; Prothrombin Time; Rats; Rats, Wistar; Thrombosis | 2010 |
Angiotensin II-mediated microvascular thrombosis.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Bradykinin Receptor Antagonists; Endothelin Receptor Antagonists; Hypertension; Male; Mice; Mice, Inbred C57BL; Microvessels; Platelet Aggregation; Receptors, Angiotensin; Receptors, Bradykinin; Receptors, Endothelin; Thrombosis | 2010 |
Exacerbation of thrombotic events by diesel exhaust particle in mouse model of hypertension.
Topics: Air Pollutants; Angiotensin II; Animals; Blood Platelets; Blood Pressure; Carbon Dioxide; Disease Models, Animal; Dose-Response Relationship, Drug; Hypertension; Male; Mice; Oxygen; Partial Thromboplastin Time; Particulate Matter; Platelet Aggregation; Prothrombin Time; Thrombosis; Vehicle Emissions | 2011 |
Role of T lymphocytes in angiotensin II-mediated microvascular thrombosis.
Topics: Adoptive Transfer; Angiotensin II; Animals; Desoxycorticosterone; Disease Models, Animal; Female; Hypertension; Lymphocyte Activation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microcirculation; NADPH Oxidases; Random Allocation; Reactive Oxygen Species; Sensitivity and Specificity; T-Lymphocytes; Thrombosis | 2011 |
Remodeling of intramural thrombus and collagen in an Ang-II infusion ApoE-/- model of dissecting aortic aneurysms.
Topics: Angiotensin II; Animals; Aortic Aneurysm; Aortic Dissection; Apolipoproteins E; Collagen; Disease Models, Animal; Humans; Infusions, Intra-Arterial; Male; Mice; Mice, Knockout; Thrombosis; Vasodilator Agents | 2012 |
Angiotensin 1-7 and Mas decrease thrombosis in Bdkrb2-/- mice by increasing NO and prostacyclin to reduce platelet spreading and glycoprotein VI activation.
Topics: Angiotensin I; Angiotensin II; Animals; Bleeding Time; Blood Platelets; Bone Marrow Transplantation; Cyclic AMP; Cyclic GMP; Epoprostenol; Immunoblotting; Mice; Mice, 129 Strain; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peptide Fragments; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 2; Receptor, Bradykinin B2; Receptors, G-Protein-Coupled; Reverse Transcriptase Polymerase Chain Reaction; Sulfonamides; Thrombosis; Time Factors | 2013 |
Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats.
Topics: Angiotensin II; Animals; Cells, Cultured; Common Bile Duct; Hepatitis; Hepatocytes; Hypertension; Ligation; Liver Cirrhosis; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Thrombosis; Vasoconstrictor Agents | 2005 |
The metabolic syndrome and the risk of thrombosis.
Topics: Adiponectin; Adipose Tissue; Angiotensin II; Anthropometry; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Cohort Studies; Cytokines; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Humans; Male; Metabolic Syndrome; Obesity; Plasminogen; Prevalence; Prospective Studies; Risk Factors; Stroke; Thrombophilia; Thrombosis; Tissue Plasminogen Activator | 2007 |
Acute hypertension after traumatic renal artery thrombosis with high circulating concentrations of angiotensin II.
Topics: Aldosterone; Angiotensin II; Humans; Hypertension, Renal; Hypertension, Renovascular; Male; Middle Aged; Renal Artery; Renin; Thrombosis | 1982 |
Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis.
Topics: Angiotensin II; Animals; Binding, Competitive; Blotting, Northern; Cattle; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular; Gene Expression Regulation; Humans; Iodine Radioisotopes; Isotope Labeling; Plasminogen Activator Inhibitor 1; Protein Binding; Renin; RNA, Messenger; Thrombosis | 1995 |
Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; Cytokines; Enalapril; Fibrin; Fibrinolysin; Fibrosis; Gene Expression Regulation, Enzymologic; Growth Substances; Imidazoles; In Situ Hybridization; Kidney; Male; Plasminogen Activator Inhibitor 1; Proteinuria; Rats; Rats, Sprague-Dawley; Renal Circulation; Renin; RNA, Messenger; Tetrazoles; Thrombosis; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator; Vasoconstrictor Agents | 1997 |
Aortic medial necrosis with or without thrombosis in rabbits treated with Russell's viper venom and angiotensin II.
Topics: Angiotensin II; Animals; Aorta; Aortic Diseases; Blood Pressure; Daboia; Drug Synergism; Female; Hyperlipidemias; Male; Myocardial Infarction; Necrosis; Rabbits; Reference Values; Serotonin; Thrombosis; Tunica Media; Viper Venoms | 1997 |
Autonomic neuropathy in extra-hepatic portal vein thrombosis: evidence for impaired autonomic reflex arc.
Topics: Adult; Angiotensin II; Autonomic Nervous System Diseases; Catecholamines; Female; Hemodynamics; Humans; Hypotension, Orthostatic; Liver Diseases; Male; Middle Aged; Portal Vein; Radioimmunoassay; Reflex Sympathetic Dystrophy; Reflex, Abnormal; Renin; Thrombosis | 1997 |
Do intraocular angiotensin II levels, plasma prothrombotic factors and endothelial dysfunction contribute to proliferative diabetic retinopathy?
Topics: Aged; Angiotensin I; Angiotensin II; Aqueous Humor; Blood Pressure; Cell Division; Cross-Sectional Studies; Diabetic Retinopathy; Endothelium, Vascular; Female; Hemorheology; Humans; Lipoprotein(a); Male; Neovascularization, Pathologic; P-Selectin; Retinal Neovascularization; Retinal Vessels; Thrombosis | 1998 |
Association between the molecular pathobiology of essential hypertension and thrombotic diseases.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Genetically Modified; Coronary Disease; Disease Models, Animal; Humans; Hypertension; Mice; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Thromboplastin; Thrombosis | 2000 |
Inhibition of arterial thrombogenesis by quinapril but not losartan.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Dose-Response Relationship, Drug; Isoquinolines; Losartan; Male; Platelet Aggregation; Quinapril; Rats; Rats, Sprague-Dawley; Superoxides; Tetrahydroisoquinolines; Thrombosis | 2000 |
Renin/angiotensin system in hypertension after traumatic renal-artery thrombosis.
Topics: Abdominal Injuries; Adult; Aldosterone; Angiotensin II; Blood Pressure; Erythropoietin; Female; Hemoglobins; Humans; Hypertension, Renal; Male; Middle Aged; Nephrectomy; Renal Artery; Renin; Sodium; Thrombosis | 1976 |
Mechanism of renal hypertension.
Topics: Angiotensin II; Animals; Blood Pressure; Dogs; Female; Humans; Hypertension, Renal; Kidney; Models, Biological; Nephrectomy; Renal Artery; Renal Artery Obstruction; Renin; Saralasin; Sodium; Thrombosis; Vasoconstrictor Agents | 1976 |
Renal occlusion phlebography: applicability of the balloon catheters.
Topics: Adenocarcinoma; Angiotensin II; Humans; Kidney Diseases; Kidney Neoplasms; Phlebography; Pyelonephritis; Renal Artery; Renal Veins; Retroperitoneal Neoplasms; Thrombosis | 1978 |
Renal trauma and hypertension: the role of renin.
Topics: Adult; Angiotensin II; Female; Hematoma; Humans; Hypertension, Renal; Kidney; Kidney Diseases; Male; Middle Aged; Nephrectomy; Renal Artery Obstruction; Renin; Thrombosis | 1976 |
Renal vascular adjustments to partial renal venous obstruction in dog kidney.
Topics: Angiotensin II; Animals; Dogs; Female; Hemodynamics; Kidney; Male; Papaverine; Receptors, Adrenergic, alpha; Renal Circulation; Renal Veins; Sympathetic Nervous System; Thrombosis; Venous Pressure | 1987 |
Injury and repair in arterial tissue: contraction and blebbing of endothelial cells in atherogenesis and thrombogenesis and abnormal secretion of sex hormone in Takayasu's disease.
Topics: Adolescent; Adult; Angiotensin II; Animals; Aorta; Aortic Arch Syndromes; Arteries; Arteriosclerosis; Cholesterol; Endothelium; Epinephrine; Estrogens; Female; Fluorescent Antibody Technique; gamma-Globulins; Gonadal Steroid Hormones; Humans; Lipoproteins, LDL; Male; Microscopy, Electron; Microscopy, Electron, Scanning; Pregnanediol; Rabbits; Regeneration; Takayasu Arteritis; Thrombosis; Vascular Diseases | 1974 |
Hyponatraemia and renovascular hypertension. Case report with plasma renin and vascular sensitivity studies.
Topics: Adult; Angiotensin II; Female; Humans; Hypertension, Renal; Hyponatremia; Nephrectomy; Phentolamine; Renal Artery; Renal Artery Obstruction; Renin; Thrombosis; Urography; Water-Electrolyte Balance | 1968 |
Systemic effects of intestinal revascularization.
Topics: Adult; Aged; Angiotensin II; Embolism; Female; Heart Failure; Hepatic Encephalopathy; Humans; Male; Mesenteric Vascular Occlusion; Middle Aged; Postoperative Complications; Pulmonary Edema; Thrombosis; Urination; Water-Electrolyte Balance | 1969 |
Treatment of acute ischemic pain in the leg by induced hypertension.
Topics: Acute Disease; Adult; Aged; Analgesics; Angiotensin II; Female; Humans; Hypertension; Injections, Intravenous; Intermittent Claudication; Ischemia; Leg; Male; Middle Aged; Thrombosis | 1969 |
[Effects of angiotensin on platelet aggregation].
Topics: Adenine Nucleotides; Angiotensin II; Blood Platelet Disorders; Blood Platelets; Catecholamines; Humans; Hypertension; Thrombosis | 1969 |
[Internal therapy of peripheral arterial blood circulation disorders].
Topics: Adenosine Triphosphate; Aged; Angiotensin II; Anti-Bacterial Agents; Blood Pressure; Chlorpromazine; Chronic Disease; Collateral Circulation; Coumarins; Epinephrine; Ergot Alkaloids; Exercise Therapy; Femoral Artery; Fibrinolytic Agents; Humans; Infusions, Parenteral; Male; Methoxamine; Nicotinic Acids; Papaverine; Popliteal Artery; Propranolol; Reserpine; Sympatholytics; Sympathomimetics; Thrombosis; Vascular Diseases | 1970 |
[Renovascular hypertension. I. Comparison of the different examinations and tests for detection. Superiority of intravenous urography].
Topics: Angiography; Angiotensin II; Humans; Hypertension, Renal; Kidney Function Tests; Radioisotope Renography; Renal Artery Obstruction; Renin; Thrombosis; Urography | 1971 |
Arteriovenous fistulae in rabbit kidney studied by dye-dilution technique and by angiography.
Topics: Anesthesia, Intravenous; Aneurysm; Angiography; Angiotensin II; Animals; Arteriovenous Fistula; Blood Pressure Determination; Dye Dilution Technique; Hypertension; Ischemia; Kidney; Norepinephrine; Phentolamine; Punctures; Rabbits; Spectrophotometry; Thrombosis; Trimethaphan; Urinary Catheterization; Vasopressins | 1972 |
Arterial endothelial permeability and vascular disease. The "trap door" effect.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Arteries; Arteriosclerosis; Blood Platelets; Bradykinin; Capillary Permeability; Endothelium; Female; Intercellular Junctions; Lipoproteins; Macromolecular Substances; Microscopy, Electron; Norepinephrine; Rats; Serotonin; Thrombosis; Vascular Diseases | 1973 |
Interaction of angiotensin with disseminated intravascular coagulation: a possible mechanism in the genesis of acute renal failure.
Topics: Acute Kidney Injury; Angiotensin II; Animals; Blood Cell Count; Capillaries; Creatinine; Disseminated Intravascular Coagulation; Fibrinogen; Kidney; Kidney Cortex Necrosis; Kidney Glomerulus; Rabbits; Renin; Thrombin; Thrombosis | 1973 |
Hyperlipidemia in experimental disseminated intravascular coagulation.
Topics: Aminocaproates; Analysis of Variance; Angiotensin II; Animals; Cholesterol; Disseminated Intravascular Coagulation; Epinephrine; Fatty Acids, Nonesterified; Female; Hemolysis; Hyperlipidemias; Kidney Cortex Necrosis; Kidney Glomerulus; Lactates; Lipoproteins, VLDL; Liver; Male; Phenoxybenzamine; Propranolol; Rabbits; Thrombin; Thrombosis; Triglycerides | 1974 |
Acute renal failure in disseminated intravascular coagulation. Experimental studies of the induction and prevention of renal fibrin deposition.
Topics: Acute Kidney Injury; Adrenal Cortex Hormones; Angiotensin II; Animals; Anticoagulants; Blood Platelets; Disease Models, Animal; Disseminated Intravascular Coagulation; Endotoxins; Fibrin; Fibrinolysis; Kidney; Kidney Glomerulus; Mechlorethamine; Microscopy, Electron; Polymyxins; Pressure; Rabbits; Receptors, Adrenergic; Shwartzman Phenomenon; Thrombin; Thrombosis; Ureter | 1974 |